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Abstract / The provision of care that enhances the
quality of life at the end of life is a fundamental goal of
palliative care services. This pilot study explored the
application of the Quality of Life at the End of Life
(QUAL-E) instrument in a sample of 52 patients who
were hospitalized in two metropolitan Western Aus-
tralian hospitals. Participants were given the option to
complete the QUAL-E either as a self-report (n=9, 17.3
percent) or, aided by a research assistant, as a struc-
tured interview (n=43, 82.7 percent). The instrument
demonstrated patient acceptability and face validity,
particularly when it was administered with the assis-
tance of a research assistant. Despite having difficulty
with some questions, patients expressed their appreci-
ation at being given the opportunity to contribute to the
research and to reflect upon and give voice to their
thoughts and feelings. Health practitioners indicated
that the instrument could be a valuable tool for holistic
assessment and service evaluation. We suggest that
minor changes be made to the QUAL-E before it is
used further in an Australian context; we also recom-
mend that this instrument be tested in other settings
and populations.  
Résumé / L’objectif fondamental des soins palliatifs
est de dispenser des soins de santé qui améliorent la
qualité de vie des malades en fin de vie. Notre projet
pilote avait pour objectif d’évaluer le QUAL-E, un ins-
trument de recherche destiné à connaître la qualité des
soins de fin de vie chez 52 patients hébergés dans
deux hôpitaux urbains en Australie occidentale. Les
participants avaient deux choix: soit de remplir le ques-
tionnaire par eux-mêmes (n=9, 17,3 pourcent) ou soit
de répondre au questionnaire sous une autre forme : un
INTRODUCTION
The journey toward the end of life is complex.
Patients and their families confront challenges
such as symptom control, physical and cognitive
decline, psychosocial preparation for death,
and frequent interactions with health services.
Research on quality of life (QOL) at the end of life
(EOL) has established that factors contributing
to a “good death” for patients and their families
include: “pain and symptom management, prepa-
ration for death, achieving a sense of completion,
decisions about treatment preferences and being
treated as a ‘whole person’” (1, p. 2476). Despite
the fact that most people wish to die at home (2),
in Australia, more than half of all deaths occur in
an inpatient hospital setting (3), and less than a
third of patients dying in hospital have contact
with palliative care services (PCS) (4, 5).
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interview structuré, administré par un assistant de
recherche (n=43,82,7 pourcent). Cet instrument
 d’évaluation a été bien reçu et sa validité est apparente
particulièrement lorsque conduite par l’assistant de
recherche. En dépit du fait qu’ils ont eu de la difficulté
à répondre à certaines questions, les patients ont
exprimé leur appréciation d’avoir eu l’opportunité de
contribuer à cette recherche et d’avoir pu réfléchir et
exprimer leurs opinions et leurs propres sentiments.
Les professionnels de la santé ont indiqué que cet ins-
trument pourrait devenir un outil important pour faire
une évaluation globale du malade et pour évaluer la
qualité des soins dispensés. On suggère cependant de
faire des modifications mineures au QUAL-E avant de
l’utiliser en Australie. On recommande également d’en
faire l’évaluation auprès d’autres groupes de patients et
dans d’autres milieux. 
Patients with a life-limiting illness benefit from
involvement with PCS (6). This multidisciplinary,
holistic approach to care offers support to patients
and their families so that patients can live as
actively as possible in whichever setting they
prefer as they advance toward the EOL (7). PCS
have been shown to improve patient outcomes in
terms of physical and psychological symptom
control, QOL, and use of hospital services (6). PCS
access is no longer limited to cancer patients.
Other terminally ill patients, such as those with
heart failure or end-stage renal disease, are being
referred to PCS for physical and emotional
symptom management and support (7). 
This paper reports on a pilot study that aimed
to assess the suitability and feasibility of an instru-
ment to measure QOL at the EOL in an Australian
population. Previous research has defined the
characteristics of QOL at the EOL from the per-
spectives of patients’ family members and health-
care workers rather than from the perspective of
patients themselves (8-10). Participating in
research during the EOL period can be difficult for
patients due to their declining physical and cogni-
tive abilities and high symptom burden, and
ethical considerations can also be an obstacle (11,
12). Furthermore, research into this phase of life is
complicated by unpredictable illness trajectories.
After a long period of slow decline, cancer
patients often deteriorate rapidly near the EOL.
However, those with other terminal illnesses may
follow a more erratic pattern, with several
episodes of decline followed by improvement,
making it difficult to predict when death will
occur (7). It can be hard to determine when
someone has reached the EOL phase, which has
been variously defined as ranging from the hours
before death to the last year of life (5). 
METHODS
Several instruments have been developed to
measure QOL at the EOL, allowing interventions
and models of care to be evaluated (13). These
instruments are different from other QOL meas-
ures in that they place less emphasis on physical
functioning and more on the patient’s social and
spiritual dimensions (13).
We considered the Quality of Life at the End of
Life (QUAL-E) instrument to be a suitable one for
assessing QOL at the EOL (13, 14). It was induc-
tively developed from two focus group studies
conducted with terminally ill patients, their carers,
and health professionals, as well as a follow-up
national survey (10). Psychometric testing of the
QUAL-E has established the instrument’s robust-
ness across diverse sample groups with different
disease trajectories and stability over time; it has
also demonstrated the instrument’s construct
validity (15). Item reduction and factor analysis
yielded an instrument with 21 questions covering
four domains: symptom impact — identifying
symptoms (α=0.87), relationship with the health-
care provider (α=0.71), preparation for the end of
life (α=0.68), and life completion (α=0.8). A final,
open-ended question was included to allow
respondents to add any comments they might
wish to make. 
Acceptability and Face Validity 
of the QUAL-E Instrument
“Acceptability” refers to how well an instrument
or intervention meets the needs of the target pop-
ulation and organizational setting. “Face validity”
is a subjective evaluation of whether an instru-
ment measures a construct of interest and pro-
vides insight into how participants might inter-
pret and respond to the items the instrument
contains (16). In this study, the acceptability and
face validity of the QUAL-E was evaluated
through instrument completion and field notes of
researcher-participant interactions. Interviews
with three senior PCS nurses were also conducted.
These nurses were asked to describe how they
selected patients for inclusion in the project, indi-
cate what impact the research project had on daily
practice, and identify any effects the research had
on the patients involved. Interviews were audio-
taped and transcribed verbatim prior to being
analyzed.
Study Sample
The study population was comprised of patients
receiving palliative care at two acute care public
hospitals in Perth, Western Australia. At both
study hospitals, patients could be referred to PCS
for symptom control, discharge planning, or ter-
minal care at any time during their hospitaliza-
tion. PCS staff identified potential study partici-
pants during weekly team meetings. Others have
undertaken a similar process (17). Senior clinical
nurses within each hospital’s PCS, in consultation
with medical staff, identified eligible patients
based on established criteria. Patients had to be
older than 18, physically and emotionally able to
participate, aware of their terminal prognosis,
diagnosed with cancer or multiple organ failure
but not dementia, currently admitted as an inpa-
tient under the care of PCS in either of the two
hospitals, and able to understand written and
spoken English.
Data Collection 
Potential participants identified by PCS were
approached by a research assistant (RA) who



















































study was being conducted in the hospital to trial
a questionnaire that could help patients provide
information to PCS. The patients were informed
that the questionnaire had been developed in the
United States but had not yet been used in Aus-
tralia. The RA explained that participation would
involve patients completing the questionnaire
either themselves (as a self-report) or with her
assistance. She also told the patients that they
would be invited to offer feedback about their
experience of answering the QUAL-E questions.
Interested patients were supplied with written
information about the study and given the oppor-
tunity to ask questions. Those who were willing to
participate were asked to provide their consent.
Demographic data were taken from the patients’
medical files to minimize the amount of time par-
ticipants had to spend responding to the question-
naire.
One RA in each hospital administered the
QUAL-E to enhance the fidelity of the data collec-
tion. A consistent approach to administering the
instrument was developed, whereby the RA sat by
the patient’s bed holding the questionnaire to
enable the patient to see the response sets. QUAL-
E questions were asked and the patient’s difficul-
ties clarified in a consistent manner. Helping
patients to complete the questionnaire allowed the
RA an opportunity to assess the relative ease with
which patients could answer the questions and
thereby to identify problematic items. The RA
invited feedback about the experience of complet-
ing the QUAL-E either after she had assisted
patients to complete the instrument or after she
had collected their self-reported responses. This
feedback was documented in field notes. 
Ethical Considerations
Ethics approval was granted by the supporting
university and the two hospitals involved in the
study. All potential participants were given an
information sheet and a consent form to facilitate
their provision of informed consent. In accordance
with our recruitment procedures, and to enhance
the process of obtaining informed consent, we
included a family information form that partici-
pants could give to their interested relatives. 
We encountered a number of hurdles during
the ethical review of this study. The QUAL-E
instrument is specifically designed for use with
patients who have accessed a range of services
and who have a variety of diagnoses, and our
original intention was to include a wide popula-
tion of patients. However, there was some concern
that asking questions about palliative care and
dying would cause these patients distress, partic-
ularly if they had been unaware of the terminal
nature of their illness. For this reason, we only
approached patients who were receiving PCS.
There was also concern that we would not be able
to identify a sufficient number of patients nearing
death and still able to participate. However, the
pilot nature of the study allowed us to explore the
acceptability of administering the QUAL-E in this
patient population. 
Analysis
A coding template was used to record the number
of times patients made comments (verbal or
written) or omitted specific questions. The com-
pleted coding template is included as Table 1. This
template helped us to identify questions that were
problematic or lacked acceptability or validity.
Field notes made of interactions with participants
and audio recordings of interviews with the
senior PCS nurses were transcribed verbatim. Two
experienced researchers coded and analyzed the
qualitative data independently and resolved any
discrepancies through joint discussion. 
RESULTS
The PCS identified a convenience sample of 78
patients who met the inclusion criteria. A total of
52 patients completed the questionnaire: 20 from
hospital A, and 32 from hospital B (response rate:
67 percent). Male patients made up 44 percent of
the sample, and the mean age of respondents was
67.35 years. Cancer was the primary diagnosis for
86 percent of the sample (n=45), and noncancer
diagnoses (such as cardiovascular disease, liver
failure, end-stage renal disease, and other nonma-
lignancies) accounted for the rest. Length of stay
ranged from 2 to 102 days, with a median stay of
5 days. Nine of the 52 participants (17.3 percent)
chose to complete the QUAL-E as a self-report,
while 43 (82.7 percent) accepted the offer of help
from the RA and completed the questionnaire as a
structured interview.
Problematic Questions
A total of 40 respondents (77 percent) completed
all items on the QUAL-E questionnaire. Unan-
swered questions were most often those con-
cerned with symptom impact (questions 1-4),
patients’ relationship with the healthcare provider
(questions 5-9), patients’ positive difference in the
lives of others (question 15), and patients’ sense of
meaning in their lives (question 18). There were 2
patients who did not answer the question about
overall QOL (question 21); 15 were unable to iden-
tify more than two bothersome physical symp-
toms (questions 1-4) and 4 of the 9 patients who
self-administered the instrument left the symptom
impact questions (questions 1-4) blank.
A number of respondents had sought help to
understand the meaning of questions related to
physical symptoms and abstract concepts. It was
evident that their fluctuating symptoms, the psy-
chosocial impact of their illness, and the number
of people involved in their care made it difficult
for some patients to quantify physical symptoms.
The strength of their relationships with members
of the healthcare team was also difficult for them
to determine. In addition, a number of patients
reported that the wording of questions about
bothersome physical symptoms was confusing.
Domain Issues
Three of the four domain subscales raised issues
for the participants: relationship with the health-
care provider, preparation for the end of life, and
life completion. Analysis of field notes document-
ing the interactions between the RA and patients


























Table 1 / Coding Template for the Quality of Life at the End of Life (QUAL-E) Study
        Required Verbal Emotional Incomplete
QUAL-E: A measure of quality of life at the end of life interpretation comment response data
Question Field notes Self-report
Symptom impact — identifying symptoms 3 3
   1.  During the last week, how often have you experienced 
[symptom]? 2 4
   2.  During the last week, on average, how severe has 
[symptom] been? 1 4
   3.  During the last week, how much has [symptom] interfered 
with your ability to enjoy your life? 2 4
   4.  How worried are you about [symptom] occurring 
in the future? 1 1 4
Relationship with the healthcare provider 
   5.  Although I cannot control certain aspects of my illness, 
I have a sense of control about my treatment decisions. 2 3 2
   6.  I participate as much as I want in the decisions 
about my care. 2 1 2
   7.  Beyond my illness, my doctor has a sense of who I am 
as a person. 2 8 1
   8.  In general, I know what to expect about the course 
of my illness. 3 1
   9.  As my illness progresses, I know where to go to get answers 
to my questions. 3
Preparation for the end of life
 10.  I worry that my family is not prepared to cope with the future. 2 1
 11.  I have regrets about the way I have lived my life. 1 1
 12.  At times, I worry that I will be a burden to my family.
 13.  I worry about the financial strain caused by my illness. 1
 14.  I have been able to say important things to those close to me. 3 2
Life completion
 15.  I make a positive difference in the lives of others. 2 2 4
 16.  I have been able to help others through time together, gifts, 
or wisdom. 2 1
 17.  I have been able to share important things with my family. 0 1 1
 18.  Despite my illness, I have a sense of meaning in my life. 6 6
 19.  I feel at peace. 2
 20.  There is someone in my life with whom I can share 
my deepest thoughts. 3 2
 21.  How would you rate your overall quality of life? 2 2


























vided insight into the sources of participants’ dif-
ficulties. 
Relationship with the healthcare provider
A total of 12 of the 23 interview respondents (52
percent) had questions or comments related to
this domain. They appeared to be confused as to
which doctor was being referred to in the question
about whether the doctor seemed to have a sense
of who the patient was as a person (question 7).
Many respondents referred to their general prac-
titioners when the instrument was intended to
extract information about PCS doctors. Partici-
pants also noted that they had several doctors,
many of whom were part of a large team whose
individual members only saw them briefly.
In addition, four patients needed assistance
with question 5, which asked about control over
the illness and treatment decisions. Participants
needed the RA to clarify what was meant by
“control” and explain which of their treatments
should be assessed in this respect. For example,
one respondent had difficulty quantifying her
sense of control because she was “not having any
treatment at that time and therefore there [were]
no decisions to be made.” Another respondent
remarked that she had a number of different
doctors; with some, she felt in control, but with
others she did not. It was also evident that the
complexity of care made it difficult for some
respondents to determine whether the doctor “has
a sense of who I am as a person” (question 7). 
Preparation for the end of life
Two respondents needed clarification of the Likert
scale response levels, and one respondent, when
asked about regrets in life (question 11), was
unable to answer, despite receiving assistance
from the RA. Another became emotional when
this question about regrets caused  her to consider
the burden her condition placed on her family. Yet
another reflected on her family’s financial future
now that she was unable to work; with her per-
mission, the RA asked the PCS to follow-up on
this. Three respondents did not understand the
question about saying important things to those
close to them (question 14). One considered it the
most “unusual question…I have ever been con-
fronted with,” while another contextualized the
question by saying, “I give advice to those around
me.”
Life completion 
Questions in the life completion domain raised the
most issues among participants. Many asked for
help to understand what, for them, was an
abstract concept, or they made comments indicat-
ing that these questions raised transcendental con-
cerns. A question about helping others through
time together, gifts, or wisdom (question 16) con-
fused some respondents; one participant was
unable to answer it until his wife remarked that
he had recently received a letter from a family
member regarding this very thing. Another said,
“That sounds religious to me.” Three questions
referring to communication with “those close to
me” (question 14), “my family” (question 17), and
“someone in my life” (question 20) were consid-
ered to be, as one PCS nurse put it, duplicative
because “family is the most important thing to
most people.” Lastly, a question probing patients’
sense of having someone with whom they could
share their deepest thoughts (question 20) evoked
emotional responses from respondents as they
described supportive family members or friends. 
Acceptability of the QUAL-E Instrument to
Western Australian Palliative Care Patients
While participants demonstrated some difficulties
with particular domains, their overall responses
indicated that completing the QUAL-E was a pos-
itive experience for them. A number of patients
expressed eagerness to finish the interview despite
interruptions. While some patients found the ques-
tions “easy,” some also used descriptors such as
“thoughtful,” “interesting,” and “sensible.” One
participant commented that the questions “were
not superficial,” adding, “Superficial questions
would be an insult.” Data collected from the PCS
nurses revealed that there had been no negative
feedback from patients and no evidence that they
had experienced lasting emotional distress as a
result of their participation. The questionnaire took
between 15 and 25 minutes to complete. One
patient felt exhausted by it; another stated that he
didn’t think the questionnaire applied to him, as
he didn’t consider himself to be at the end stage
yet.
Assistance with Completion 
One aspect of this study was a consideration of
how feasible it was to conduct research in an inpa-
tient PCS. The RAs reported that there were
numerous interruptions during the completion of
the questionnaires, but this did not seem to
adversely affect the process. 
All of the participants at hospital A and 23 par-
ticipants at hospital B requested the RA’s assis-
tance for a variety of reasons. Some wanted help
because they had physical limitations such as
poor vision or lethargy; others needed emotional
support. One participant remarked, “I couldn’t do
it on my own.” At times, the RA would have to
explain certain questions or use simpler English to
help participants understand. For the demo-
graphic questions, the RA sometimes had to deter-
mine participants’ education levels, as many
respondents were elderly and could not convert
the grade levels of the school system of their day
into contemporary grade levels. Some participants
required prompting when asked to describe both-
ersome symptoms such as pain, nausea, or
fatigue.
On three occasions, the RA noticed that the par-
ticipant was becoming emotional when answering
particular questions. Each time, the RA offered
comfort and volunteered to stop, but all three
patients asked to continue with the questionnaire.
The RA informed the PCS nurse of the patients’
distress. On another occasion, the RA facilitated
an information flow, with the patient’s consent,
between a patient and PCS when the patient dis-
closed that she was concerned about going home
as she lived in a rural area where few services
were available.
PCS Nurse Interviews
Thematic analysis of data collected from the PCS
nurses revealed that in determining a patient’s
suitability for inclusion in the study, the nurses
primarily considered the patient’s cognitive
ability, level of symptom burden, and likelihood
of becoming emotionally distressed. Data from the
nurse interviews on the applicability of the
QUAL-E in clinical practice revealed that, due to
its holistic nature, the instrument was perceived
as a particularly useful tool for assessing patients’
emotional status or for prompting patients to
voice their concerns as the EOL approached. This
suggests that the QUAL-E could also be used by
social workers to identify and address psychoso-
cial issues. The perceived barriers to using the
instrument in practice related to a lack of staff
time to administer the QUAL-E as an interview.
The PCS nurses were also concerned that using
the instrument would raise problems that clini-
cians did not have the resources to resolve:
“[With] some of the questions, we’d need to be
careful that we can respond to them.” They
thought that it might be best to give the question-
naire to patients to complete themselves at a time
conducive to self-reflection or to administer it in
an abridged format. 
DISCUSSION
The results of this study support the acceptability
of the QUAL-E to this sample of Western Aus-
tralian hospitalized palliative care patients. A
striking finding was that the interview application
of the QUAL-E generated broader and more
detailed responses to important aspects of care
than the self-administered instrument. Most inter-
view respondents understood the questions and
could answer within the response sets, but
patients’ unsolicited comments suggested that a
number of items prompted descriptions of impor-
tant existential or psychosocial concerns that
could be addressed by PCS. While the interview
option was designed to facilitate participation, it
provided an unexpected opportunity to identify
EOL problems, such as financial strain or lack of
rural services, which may not have been
addressed during hospitalization. 
This study demonstrated that, due to the com-
plexity and fluctuating nature of their symptoms,
patients encountered difficulties when asked to
selectively quantify their physical experiences.
Their difficulties were compounded by their con-
fusion over the format of the symptom-impact
questions, which shifted focus from the previous
month to the last week. 
The degree to which patients at the EOL feel
that they are seen as a whole person by their
healthcare providers and are being kept informed
about treatment decisions are crucial aspects of
high-quality care (13). The fact that the RAs were
often required to help respondents contextualize
items related to their relationships with their
healthcare providers indicated that the questions
in this domain should be adjusted for an Aus-
tralian population. Amending the instrument by
including a clarifying note such as, “My [oncolo-
gist/palliative care team/general practitioner]
sees me as a whole person” could be useful in the
Australian context.
Most problematic for participants were ques-
tions about meaning and positive contributions to
others. Meaning in life is a construct that is posi-
tively correlated to happiness and life satisfaction
(18). Some participants understood meaning to be
related to legacy, while others linked it to func-
tional ability or spirituality. One way to guide
respondents in considering this abstract concept
would be to add to the QUAL-E a glossary of
prompts such as: “Meaning is ‘the sense made of,
and significance felt regarding, the nature of one’s
being and existence’” (18, p. 81). Our findings
indicate that further research is merited to
develop an understanding of meaning as a
concept that can be articulated by patients at the
EOL. 
Patients’ difficulty with some items may have
been compounded by the confusion they felt
when presented with questions that involved a
shift between past and present. This may be par-
ticularly problematic for patients at an early stage
of the palliative care journey. For example, ques-
tion 17 reads, “I have been able to share important
things with my family,” and not, “I am able to



















































not clear whether the final question — “How
would you rate your overall quality of life?” —
refers to respondents’ QOL at the time they com-
pleted the questionnaire or their QOL as a whole. 
Clinicians’ concerns about having to address
problems raised and identified by the question-
naire must be acknowledged. If the QUAL-E is to
be used as a patient assessment or screening tool,
then it needs to be supported with an action plan
and staff education on how to address any prob-
lems that arise — for example, staff should be told
what services and supports to suggest to patients
who indicate that they are under financial strain.  
In considering the feasibility of administering
and processing the instrument (19), we concluded
that it was likely that having an RA on hand to
answer participants’ questions and assist those
who felt unable to self-administer the question-
naire increased participation in the study. Approx-
imately 83 percent of participants requested that
the RA administer the QUAL-E, often due to their
physical limitations or general weakness. In addi-
tion, the RA often needed to explain to partici-
pants the abstract concepts raised in some of the
questions or articulate questions in simpler
English. Patients who felt ill or sleepy did not
have sufficient concentration to grasp intangible
ideas. Moreover, the RA provided support or
referrals for patients who became emotional in
responding to certain questions; the RA also com-
municated to PCS any concerns or needs partici-
pants had that PCS could address. 
We anticipated that responding to the QUAL-E
would sometimes be stressful for hospitalized
patients who were dealing with EOL issues. Both
of the RAs employed to collect the data were reg-
istered nurses. One had recent acute hospital
experience and the other was working within
PCS. Both were alert to the possibility that
patients could become upset, and they were ready
to provide emotional support as needed. Any par-
ticipant who became emotional was given the
option to stop the interview. However, all chose to
continue when the emotional moment had
passed. While no information from the QUAL-E
responses was routinely provided to clinical staff,
the PCS nurses were informed about any patients
who had expressed upset or disclosed psychoso-
cial concerns. The RAs had a clearly defined role
as researchers only, not as therapists; however,
participants in previous research conducted at the
EOL have found that the opportunity to discuss
difficult issues related to death and dying is
“thera peutic, cathartic, educational, empowering,
altruistic and social” (20, p. 173).
While we can expect patients in the EOL period
to become emotional when speaking about death
and dying, it is not always clear to those who
develop research questionnaires which questions
will prompt such a response. In assisting partici-
pants to complete the QUAL-E questionnaire we
had an ideal opportunity to identify these ques-
tions and thus to develop strategies to minimize
the risk of prompting emotional responses (21).
We developed a protocol for dealing with patient
distress, and we ensured that our RAs had experi-
ence and training in identifying verbal and non-
verbal indicators of that distress.
We also found that by employing an RA to help
participants complete the questionnaire, we were
able to minimize disruption in the inpatient envi-
ronment and the demands on staff. With sufficient
time and flexibility, the RA could tailor data col-
lection to accommodate each patient’s condition
and the demands of clinical care. A recent study
(22) proposes that the QUAL-E questionnaire be
reduced to 17 items in four domains.  
LIMITATIONS 
A limitation of this study was that by nominating
patients to participate in it, PCS were interested in
protecting the most vulnerable. Consequently, our
results may not reflect the experiences of all PCS
users. While the QUAL-E is designed for use with
patients who “may or may not have acknowl-
edged the terminal nature of their disease” (13,
p. 830), we were unable to pilot the instrument
with patients who were not already using PCS.
Delayed access to PCS may deny patients the
opportunity to participate in decision making and
to prepare for death before experiencing signifi-
cant physical and cognitive decline (23). Our find-
ings demonstrate that exploration of patients’
QOL at the EOL using an instrument such as the
QUAL-E can help to identify problems that are
amenable to intervention, particularly when the
instrument is administered as an interview.
There is no doubt that patients who are at the
EOL are vulnerable and need to be offered addi-
tional protection by ethics committees (11). Never-
theless, our finding that patients often experience
some benefit from participating in research at the
EOL supports the initiative to conduct further
studies. Such inquiry could inform healthcare
education and practice and facilitate timely refer-
ral to PCS, particularly for noncancer patients (6,
7, 23). 
CONCLUSION
This study highlights the importance of pilot
testing instruments thoroughly. Despite rigorous
psychometric analysis of the instrument, our
study revealed that some patients experienced dif-
ficulties while completing the QUAL-E question-
naire. Providing a trained RA to assist those
patients should be included in the methodology of
instrument development and testing. We consider
this instrument to be a potentially valuable screen-
ing tool for conducting holistic patient assess-
ments that encompass the physical, psychological,
emotional, and social aspects of a patient’s
journey at the EOL. However, clinicians’ state-
ments about the problems they may have in
addressing patients’ concerns must be acknowl-
edged. 
QOL at the EOL is the primary goal of PCS;
however, the experience of patients in this stage of
life is under researched because it is difficult to
access this population. It is imperative that we
conduct studies that meet the requirements of
ethics committees. However, it is also important
that we offer patients the opportunity to benefit
from participation in research and allow society to
benefit from the results of research — particularly
that related to QOL and service or program eval-
uation. The QUAL-E questionnaire may prove to
be an important tool for evaluating PCS, but if it is
to become so the sample of respondents must be
representative of the service population. It is
therefore vital that we facilitate researchers’ access
to vulnerable patients at the EOL from culturally
and linguistically diverse backgrounds.
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